Skip to main content
. 2022 May 17;27(8):e642–e649. doi: 10.1093/oncolo/oyac086

Table 4.

Adverse events occurring in ≥10% of the patients, irrespective of causality.

All grade ≥Grade 3
n % n %
Non-hematological adverse events
Hypertension 32 91 3 9
Fatigue 24 69 1 3
Anorexia 22 63 5 14
Proteinuria 18 51 3 9
Diarrhea 17 49 3 9
Alopecia 15 43
Nausea 12 34 0 0
Vomiting 9 26 0 0
Epistaxis 4 11 0 0
Hematological adverse events
Neutrophil count decreased 29 83 18 51
Anemia 29 83 7 20
White blood cell count decreased 27 77 15 43
Platelet count decreased 22 63 2 6
Febrile neutropenia 4 11 4 11